ReviewJournal of internal medicine2025
Breaking with the status quo in end-of-life care through de-implementation.
Review in Journal of internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- The End of Life With Dementia in Asian Countries: Barriers, Facilitators and a Research Agenda for Advancing a Palliative Approach.Journal of the American Geriatrics Society · 2026Review
- The final year for community-dwelling older adults with dementia in an Asian setting: admissions, interventions, and caregiver burden.The journals of gerontology. Series A, Biological sciences and medical sciences · 2025Article
- An umbrella review of patient- and carer-reported measures for assessing adult end-of-life care quality outcomes.EClinicalMedicine · 2025Article
- Breaking with the status quo in end-of-life care through de-implementation.Journal of internal medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
This paper addresses the challenge of de-implementing low-value care practices in the end-of-life (EOL) context, where burdensome interventions often offer marginal life-extending benefits, incur substantial costs and diminish quality of life. We examine the complexities involved in discontinuing such practices, including clinician biases, institutional cultures favouring aggressive interventions and communication barriers among healthcare providers, patients and families. We discuss how de-implementation at the EOL is unique from other contexts, prioritizing patient-centred care rather than cost reduction. Effective communication and support for patients, families and clinicians is essential, as de-implementation often represents a shift towards what patients and families value. Our review of existing evidence underscores the need for the development and evaluation of de-implementation strategies tailored to EOL care, as described. De-implementation at the EOL requires sensitivity to the complex, emotional nature of EOL care and provides a unique opportunity to integrate palliative care approaches and improve overall EOL care quality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.